These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18492875)

  • 1. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
    Minami Y; Chung H; Kudo M; Kitai S; Takahashi S; Inoue T; Ueshima K; Shiozaki H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography.
    Hirooka M; Iuchi H; Kumagi T; Shigematsu S; Hiraoka A; Uehara T; Kurose K; Horiike N; Onji M
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S255-60. PubMed ID: 16632685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.
    Minami Y; Kudo M; Chung H; Kawasaki T; Yagyu Y; Shimono T; Shiozaki H
    AJR Am J Roentgenol; 2007 Feb; 188(2):489-94. PubMed ID: 17242259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
    Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system.
    Kudo K; Moriyasu F; Mine Y; Miyata Y; Sugimoto K; Metoki R; Kamamoto H; Suzuki S; Shimizu M; Miyahara T; Yokoi M; Horibe T; Yamagata H
    Eur J Radiol; 2007 Feb; 61(2):324-31. PubMed ID: 17049791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images.
    Minami Y; Kudo M; Chung H; Inoue T; Takahashi S; Hatanaka K; Ueda T; Hagiwara H; Kitai S; Ueshima K; Fukunaga T; Shiozaki H
    Oncology; 2007; 72 Suppl 1():111-6. PubMed ID: 18087191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
    Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence.
    Minami Y; Kudo M
    Dig Dis; 2014; 32(6):690-5. PubMed ID: 25376285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules.
    Lee JY; Choi BI; Chung YE; Kim MW; Kim SH; Han JK
    Eur J Radiol; 2012 Sep; 81(9):2281-9. PubMed ID: 21937177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy.
    Kang TW; Rhim H; Lee MW; Kim YS; Choi D; Lee WJ; Lim HK
    AJR Am J Roentgenol; 2011 Apr; 196(4):907-13. PubMed ID: 21427344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.